Details checkedClinical trial listing onlyCheckedregistry

Intracochlear Platelet-Rich Fibrin Cochlear Implantation Study

Also known as: Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation, intracochlear platelet rich fibrin administration, NCT05215197

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Regenerative Medicine

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Intracochlear administration during cochlear implantation

Confidence

83%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Turkey

Population

sensorineural, cochlear-implant

Trial IDs

Mechanism

Institution-led study applying platelet-rich fibrin intracochlearly during routine cochlear implantation surgery in sensorineural hearing loss.

Indications

Hearing Loss Sensorineural Hearing Loss

Notes

Corrected from a small-molecule row to a regenerative/procedural adjunct study. The registry describes platelet-rich fibrin administration during cochlear implantation, not a commercial drug program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT05215197

Open

Key Events

2022-01-31

Registry lists actual study start for intracochlear platelet-rich fibrin application during cochlear implantation

Clinical Trials (1)

NCT05215197

Data Checks